Impact of direct-acting antivirals and 12-week sustained viral response on clinical outcomes in patients with hepatitis C and hepatocellular carcinoma.
Kamp W, Sellers C, Stein S, Lim J, Kim H. Impact of direct-acting antivirals and 12-week sustained viral response on clinical outcomes in patients with hepatitis C and hepatocellular carcinoma. Journal Of Clinical Oncology 2019, 37: 397-397. DOI: 10.1200/jco.2019.37.4_suppl.397.Peer-Reviewed Original ResearchHepatitis C viral infectionDAA therapyOverall survivalHepatocellular carcinomaMultivariable analysisViral responseHCC patientsTumor locationTreatment allocationHigher OSMultivariable Cox proportional hazards modelsUrban tertiary care hospitalCox proportional hazards modelHCV-negative patientsChild-Pugh scoreMedian overall survivalSustained viral responseTertiary care hospitalC viral infectionKaplan-Meier curvesProportional hazards modelDAA patientsHCV patientsHepatitis CMELD score